Currently, there are 1.08M common shares owned by the public and among those 1.03M shares have been available to trade.
The company’s stock has a 5-day price change of -20.00% and -81.33% over the past three months. APDN shares are trading -83.53% year to date (YTD), with the 12-month market performance down to -99.59% lower. It has a 12-month low price of $1.45 and touched a high of $460.00 over the same period. APDN has an average intraday trading volume of 830.31K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -47.82%, -73.34%, and -92.40% respectively.
Institutional ownership of Applied Dna Sciences Inc (NASDAQ: APDN) shares accounts for 39.58% of the company’s 1.08M shares outstanding.
It has a market capitalization of $1.85M and a beta (3y monthly) value of 0.84. The earnings-per-share (ttm) stands at -$285.87. Price movements for the stock have been influenced by the stock’s volatility, which stands at 15.60% over the week and 19.52% over the month.
Earnings per share for the fiscal year are expected to increase by 73.63%, and 77.08% over the next financial year.
Looking at the support for the APDN, a number of firms have released research notes about the stock. ROTH Capital stated their Buy rating for the stock in a research note on February 12, 2021, with the firm’s price target at $24. H.C. Wainwright coverage for the Applied Dna Sciences Inc (APDN) stock in a research note released on January 14, 2021 offered a Buy rating with a price target of $14. H.C. Wainwright was of a view on December 18, 2020 that the stock is Buy, while H.C. Wainwright gave the stock Buy rating on July 20, 2020, issuing a price target of $18- $22. H.C. Wainwright on their part issued Buy rating on July 02, 2020.
